For the Inventor, By the Inventor

Enter assignee name

St. Louis, MO, United States of America

Sequoia Sciences, Inc.

USPTO Granted Patents = 15

% Expired Patents = 20.0

EPO Patents = 3

Trademarks = 3

Forward Citations = 106

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Gary R Eldridge (15 out of 17 patents)

Steven M Martin (10 out of 12 patents)

Zhongping Huang (2 out of 2 patents)

4. Michael A Ellis (1 out of 19 patents)

5. Ronald Buckle (1 out of 3 patents)

6. Peter Guzzo (1 out of 43 patents)

7. Russell B Williams (1 out of 1 patent)

8. Courtney M Starks (1 out of 1 patent)

9. John Edward Reilly (1 out of 1 patent)

10. Lu Zeng (1 out of 3 patents)

11. Peader Cremin (1 out of 1 patent)

12. Chris Lee (1 out of 1 patent)

13. Helene C Vervoort (1 out of 1 patent)

14. Marilyn Ghanem (1 out of 1 patent)

15. Ronald Neil Buckle (0 patent)

15 patents: Sort by Forward Citations

1. 10137192 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2018-11-27),

2. 10058608 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2018-08-28),

3. 9878037 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2018-01-30),

4. 9562031 - Phenethyldihydrobenzodioxolones and methods of use (2017-02-07),

5. 9504743 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2016-11-29),

6. 9492522 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2016-11-15),

7. 9415101 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2016-08-16),

8. 9415097 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2016-08-16),

9. 9149522 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2015-10-06),

10. 9149521 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2015-10-06),

11. 9017698 - Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections (2015-04-28),

12. 8324264 - Inhibitors of bacterial biofilms and related methods (2012-12-04),

13. 7612045 - Compounds, compositions and methods for controlling biofilms and bacterial infections (2009-11-03),

14. 7604978 - Inhibition of biofilm formation (2009-10-20),

15. 7367933 - Screening of chemical compounds purified from biological sources (2008-05-06),

Company Overview

Sequoia Sciences, Inc. is a biotechnology company based in St. Louis, MO, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing drug delivery systems and enhancing the efficacy of existing treatments through proprietary technologies. With a commitment to research and development, Sequoia Sciences aims to address unmet medical needs and improve patient outcomes across various therapeutic areas, leveraging its expertise in biopharmaceuticals and drug formulation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#136 in St. Louis, MO

#301 in Missouri

#21,068 in US

#39,959 in the World

St. Louis, MO, United States of America

Sequoia Sciences, Inc.

Forward Citations = 106

14 inventors:

Gary R Eldridge (15 out of 17 patents)

Steven M Martin (10 out of 12 patents)

Zhongping Huang (2 out of 2 patents)

4. Michael A Ellis (1 out of 19 patents)

5. Ronald Buckle (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sequoia Sciences, Inc.. Retrieved from https://idiyas.com/company/sequoia-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…